Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SHINDE A, Jones BL, Chen YJ, Amini A, et al
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?
    J Clin Oncol. 2018 Jun 26:JCO2018786012. doi: 10.1200/JCO.2018.78.6012.
    PubMed     Text format    


  2. FIORENTINO A, Alongi F
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?
    J Clin Oncol. 2018 Jun 26:JCO2018781005. doi: 10.1200/JCO.2018.78.1005.
    PubMed     Text format    


  3. OHRI N, Kabarriti R, Kaubisch A, Guha C, et al
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Caution When Interpreting Observational Data.
    J Clin Oncol. 2018 Jun 26:JCO2018780122. doi: 10.1200/JCO.2018.78.0122.
    PubMed     Text format    


  4. WAHL DR, Schipper MJ, Parikh ND, Owen D, et al
    Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018780882. doi: 10.1200/JCO.2018.78.0882.
    PubMed     Text format    


  5. KIM N, Seong J
    What Role Does Locally Ablative Stereotactic Body Radiotherapy Play Versus Radiofrequency Ablation in Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018781740. doi: 10.1200/JCO.2018.78.1740.
    PubMed     Text format    


  6. SANUKI N, Takeda A
    Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018782805. doi: 10.1200/JCO.2018.78.2805.
    PubMed     Text format    


  7. OLSEN JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, et al
    Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database.
    J Clin Oncol. 2018 Jun 26:JCO2018782904. doi: 10.1200/JCO.2018.78.2904.
    PubMed     Text format    


  8. SMITH GL, Das P, Herman JM, Koay EJ, et al
    Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.
    J Clin Oncol. 2018 Jun 26:JCO2018785428. doi: 10.1200/JCO.2018.78.5428.
    PubMed     Text format    


    May 2018
  9. RIAZ A, Lewandowski R, Salem R
    Radioembolization in Advanced Hepatocellular Carcinoma.
    J Clin Oncol. 2018 May 2:JCO2018777227. doi: 10.1200/JCO.2018.77.7227.
    PubMed     Text format     Abstract available


    March 2018
  10. CHOW PKH, Gandhi M, Tan SB, Khin MW, et al
    SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
    J Clin Oncol. 2018 Mar 2:JCO2017760892. doi: 10.1200/JCO.2017.76.0892.
    PubMed     Text format     Abstract available


    January 2018
  11. RAJYAGURU DJ, Borgert AJ, Smith AL, Thomes RM, et al
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.
    J Clin Oncol. 2018 Jan 12:JCO2017753228. doi: 10.1200/JCO.2017.75.3228.
    PubMed     Text format     Abstract available


    September 2017
  12. O'NEILL AF, Towbin AJ, Krailo MD, Xia C, et al
    Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 Sep 11:JCO2017735654. doi: 10.1200/JCO.2017.73.5654.
    PubMed     Text format     Abstract available


  13. REISS KA, Yu S, Mamtani R, Mehta R, et al
    Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.
    J Clin Oncol. 2017 Sep 5:JCO2017738245. doi: 10.1200/JCO.2017.73.8245.
    PubMed     Text format     Abstract available


    August 2017
  14. IKOMA N, You YN, Bednarski BK, Rodriguez-Bigas MA, et al
    Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.
    J Clin Oncol. 2017;35:2631-2638.
    PubMed     Text format     Abstract available


    May 2017
  15. PERSONENI N, Rimassa L, Giordano L, Santoro A, et al
    Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!
    J Clin Oncol. 2017 May 4:JCO2017727776. doi: 10.1200/JCO.2017.72.7776.
    PubMed     Text format    


    April 2017
  16. GROOT KOERKAMP B, Sadot E, Kemeny NE, Gonen M, et al
    Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
    J Clin Oncol. 2017 Apr 20:JCO2016718346. doi: 10.1200/JCO.2016.71.8346.
    PubMed     Text format     Abstract available


  17. BRAILLON A
    Recurrence in Early-Stage Hepatocellular Carcinoma: CpG Methylation and Smoking.
    J Clin Oncol. 2017 Apr 11:JCO2017723932. doi: 10.1200/JCO.2017.72.3932.
    PubMed     Text format    


  18. PAGLIARO LC
    Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    J Clin Oncol. 2017;35:1036-1040.
    PubMed     Text format     Abstract available


    January 2017
  19. FERRAROTTO R, Mitani Y, Diao L, Guijarro I, et al
    Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    J Clin Oncol. 2017;35:352-360.
    PubMed     Text format     Abstract available


    December 2016
  20. NAGTEGAAL ID, Knijn N, Hugen N, Marshall HC, et al
    Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2016 Dec 28:JCO2016689091.
    PubMed     Text format     Abstract available


    March 2016
  21. HALABI S, Kelly WK, Ma H, Zhou H, et al
    Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
    J Clin Oncol. 2016 Mar 7. pii: JCO657270.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: